Voyageur Pharmaceuticals (CVE:VM) Shares Down 8.8% – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price traded down 8.8% during mid-day trading on Monday . The company traded as low as C$0.15 and last traded at C$0.16. 26,941 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 337,427 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Down 8.8 %

The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84. The stock has a market capitalization of C$23.49 million, a price-to-earnings ratio of -14.50 and a beta of 0.32. The business has a 50 day simple moving average of C$0.14 and a 200-day simple moving average of C$0.09.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.